Close Menu

clinical trial

Originally published Jan. 24. This article has been updated to include comments from Crescendo Bioscience's Ted Snelgrove, who spoke at a personalized medicine conference this week in Mt. View, Calif.

By Tony Fong
NEW YORK (GenomeWeb News) – Molecular diagnostics firm T2 Biosystems is set to begin a clinical trial for its first assay targeting Candida fungal infections as it prepares to seek regulatory approval in the US next year.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.